Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Hypotension is associated with diuretic resistance in severe chronic heart failure, independent of renal function.

De Pasquale CG, Dunne JS, Minson RB, Arnolda LF.

Eur J Heart Fail. 2005 Aug;7(5):888-91.

2.

Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.

Martin FL, Chen HH, Cataliotti A, Burnett JC Jr.

Rev Cardiovasc Med. 2008 Winter;9(1):39-45. Review.

PMID:
18418308
3.

Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction.

Galve E, Mallol A, Catalan R, Palet J, Méndez S, Nieto E, Diaz A, Soler-Soler J.

Eur J Heart Fail. 2005 Aug;7(5):892-8.

4.

Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.

Goldsmith SR, Gilbertson DT, Mackedanz SA, Swan SK.

J Card Fail. 2011 Dec;17(12):982-9. doi: 10.1016/j.cardfail.2011.08.012. Epub 2011 Oct 6.

PMID:
22123359
5.

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.

Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Kodama M, Aizawa Y.

Biochem Pharmacol. 2008 Mar 15;75(6):1322-30. doi: 10.1016/j.bcp.2007.11.011. Epub 2007 Dec 3.

PMID:
18179782
6.

Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).

Miyata M, Sasaki T, Ikeda Y, Shinsato T, Kubozono T, Furusho Y, Kusumoto A, Hamasaki S, Tei C; COLD-CHF Investigators.

J Cardiol. 2012 May;59(3):352-8. doi: 10.1016/j.jjcc.2011.12.007. Epub 2012 Feb 24.

7.

Controlling the flood gates: vaptans, furosemide and the quest for a renal protective diuresis.

Costello-Boerrigter LC, Burnett JC Jr.

J Card Fail. 2011 Dec;17(12):990-2. doi: 10.1016/j.cardfail.2011.10.002. No abstract available.

PMID:
22123360
8.

[Diuretic therapy in acute heart failure].

Trullàs JC, Morales-Rull JL, Formiga F.

Med Clin (Barc). 2014 Mar;142 Suppl 1:36-41. doi: 10.1016/S0025-7753(14)70081-8. Review. Spanish.

PMID:
24930082
9.

Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?

De Vecchis R, Ciccarelli A, Pucciarelli A.

J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):571-4. doi: 10.2459/JCM.0b013e32833d37b9. Review.

PMID:
20588135
10.

Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.

Chen HH, Redfield MM, Nordstrom LJ, Cataliotti A, Burnett JC Jr.

Am J Physiol Renal Physiol. 2003 May;284(5):F1115-9.

12.

Metabolic and toxicological considerations for diuretic therapy in patients with acute heart failure.

Aspromonte N, Cruz DN, Valle R, Bonello M, Tubaro M, Gambaro G, Marchese G, Santini M, Ronco C.

Expert Opin Drug Metab Toxicol. 2011 Sep;7(9):1049-63. doi: 10.1517/17425255.2011.586629. Epub 2011 May 21. Review.

PMID:
21599566
13.
14.

The effect of continuous infusion loop diuretics in patients with acute decompensated heart failure with hypoalbuminemia.

Bleske BE, Clark MM, Wu AH, Dorsch MP.

J Cardiovasc Pharmacol Ther. 2013 Jul;18(4):334-7. doi: 10.1177/1074248412474347. Epub 2013 Feb 18.

PMID:
23424098
15.

Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure.

Ricci F, Ramírez T, Marmorato R, Vega J, Pagán P, López JE, Soto-Salgado M, Cangiano JL.

P R Health Sci J. 2013 Jun;32(2):63-7.

PMID:
23781621
16.

Reply to 'Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon?'.

Amico AF.

J Cardiovasc Med (Hagerstown). 2011 Jan;12(1):72-3. doi: 10.2459/JCM.0b013e32834090ed. No abstract available.

PMID:
21263235
17.

Diuretic management in heart failure.

Michael Felker G.

Congest Heart Fail. 2010 Jul;16 Suppl 1:S68-72. doi: 10.1111/j.1751-7133.2010.00172.x. Review.

18.

Hypochloremia and Diuretic Resistance in Heart Failure: Mechanistic Insights.

Hanberg JS, Rao V, Ter Maaten JM, Laur O, Brisco MA, Perry Wilson F, Grodin JL, Assefa M, Samuel Broughton J, Planavsky NJ, Ahmad T, Bellumkonda L, Tang WH, Parikh CR, Testani JM.

Circ Heart Fail. 2016 Aug;9(8). pii: e003180. doi: 10.1161/CIRCHEARTFAILURE.116.003180.

19.

Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.

Freda BJ, Slawsky M, Mallidi J, Braden GL.

Am J Kidney Dis. 2011 Dec;58(6):1005-17. doi: 10.1053/j.ajkd.2011.07.023. Epub 2011 Oct 19. Review.

PMID:
22014726
20.

Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.

Yoshida J, Yamamoto K, Mano T, Sakata Y, Nishio M, Ohtani T, Hori M, Miwa T, Masuyama T.

Cardiovasc Res. 2005 Oct 1;68(1):118-27.

PMID:
16002057

Supplemental Content

Support Center